A patient taking part in a clinical trial of an induced pluripotent stem cell treatment for age-related macular degeneration has experienced an adverse effect, the Japan Times reports.
A patient taking part in a clinical trial of an induced pluripotent stem cell treatment for age-related macular degeneration has experienced an adverse effect, the Japan Times reports.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.